TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -99.8% | 4 | -99.7% | 0.00% | – |
| Q1 2023 | $1,267 | +882.2% | 1,526 | +824.8% | 0.00% | – |
| Q4 2022 | $129 | -98.9% | 165 | -98.5% | 0.00% | – |
| Q3 2022 | $12,000 | -20.0% | 11,176 | -58.5% | 0.00% | – |
| Q2 2022 | $15,000 | +114.3% | 26,945 | +278.3% | 0.00% | – |
| Q1 2022 | $7,000 | +75.0% | 7,123 | +87.5% | 0.00% | – |
| Q4 2021 | $4,000 | -69.2% | 3,798 | -46.5% | 0.00% | – |
| Q3 2021 | $13,000 | -40.9% | 7,094 | -14.2% | 0.00% | – |
| Q2 2021 | $22,000 | -68.6% | 8,272 | -64.7% | 0.00% | – |
| Q1 2021 | $70,000 | +250.0% | 23,459 | +287.0% | 0.00% | – |
| Q4 2020 | $20,000 | – | 6,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 863,512 | $826,000 | 0.02% |
| Level Financial Advisors | 987 | $1,000 | 0.00% |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% |
| Fortitude Advisory Group L.L.C. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $22 | 0.00% |
| Renaissance Technologies | 36,510 | $35,000 | 0.00% |
| BARCLAYS PLC | 50,050 | $48,000 | 0.00% |
| VANGUARD GROUP INC | 206,428 | $197,000 | 0.00% |
| UBS Group AG | 7,123 | $7,000 | 0.00% |
| IFP Advisors, Inc | 844 | $3,000 | 0.00% |